secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK:        0001048477
Form:       8-K
Filed at:   2024-08-28T23:59:59+00:00
Accession:  0001048477-24-000132
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 2.05
LLM model:  deepseek-v4-flash:cloud@v2

BioMarin to cut ~225 jobs, incur $30-35M in severance costs by end of 2024
--------------------------------------------------------------------------

- Workforce reduction of ~225 employees committed on Aug 23, 2024, in organizational redesign.
- Estimated pre-tax charges of $30-35M for severance and termination benefits, mostly in H2 2024.
- Plan follows updated ROCTAVIAN strategy and discontinuation of BMN 293 development announced Aug 5, 2024.
- Notifications completed by Aug 28, 2024; reductions expected substantially complete by end of 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1048477/000104847724000132/0001048477-24-000132-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1048477/000104847724000132/bmrn-20240823.htm
  HTML page:      https://secwatch.observer/filing/0001048477-24-000132

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer